News
Podcast: Talking the cure
11 April 2024
Our team is always thinking about how to foresee and conquer the most significant industry issues facing our clients. In 2020, we launched the podcast "Talking the Cure" where we cover...
Publications
News
The emergence of environmental criteria in the pricing of medical devices
19 October 2023
Companies marketing 'polluting' medical devices will be penalised under the French Social Security Financing Bill for 2024.
News
The Social Security Financing Bill 2024: What pharmaceutical companies need to know - France
09 October 2023
The Social Security Financing Bill for 2024, which is of vital importance to the pharmaceutical industry every year, was published on Wednesday 27 September 2023. Here's what you need...
News
The “Borne Mission” Report analysis: Between hope and disappointment for the pharmaceutical industries
08 September 2023
Borne's long-awaited Report on regulation of healthcare products has fallen well short of pharmaceutical industry expectations. Indeed, it contains very few concrete proposals.
Insights and Analysis
Life Science Law Update – Key developments for pharma & device companies in EU and EU Big Five
14 August 2023
In this third issue of our Life Science and Health Care Law Update, our teams highlight key trends across life sciences regulatory, corporate, compliance, competition, and privacy...
News
Horizons 2023: Panelists discuss how European pharmaceutical companies can stay ahead of the game
20 July 2023
We were pleased to welcome industry leaders to our Life Sciences and Health Care Horizons event in Zurich, where co-head of Hogan Lovells Life Sciences and Health Care sector Jane...
News
The law aimed at improving the framework for French health care centers has finally been published!
01 June 2023
The French law n° 2023-378 of 19 May 2023 on the supervision of health care centers has finally been published in the Journal Officiel. The text, which has reached a consensus, was...
News
French decree regarding the “direct access”: a half-hearted step forward for pharmaceutical innovations
17 May 2023
Publication of the French decree regarding the experimentation of the "direct access" to pharmaceutical products with anticipated reimbursement: a half-hearted step forward for...
Insights and Analysis
Life Science Law Update – Key developments for pharma and device companies in EU and EU Big Five
31 January 2023
In this first issue of our quarterly Life Science Law Update, our teams highlight key trends across life sciences regulatory, corporate, compliance, competition, and privacy throughout the...
